BioNexus Gene Lab Corp. (BGLC)
NASDAQ: BGLC · Real-Time Price · USD
5.10
-1.53 (-23.08%)
At close: Jul 18, 2025, 4:00 PM
4.730
-0.370 (-7.25%)
After-hours: Jul 18, 2025, 6:51 PM EDT
BioNexus Gene Lab Market Cap
BioNexus Gene Lab has a market cap or net worth of $9.16 million as of July 18, 2025. Its market cap has increased by 10.34% in one year.
Market Cap
9.16M
Enterprise Value
8.53M
1-Year Change
10.34%
Ranking
Category
Stock Price
$5.10
Market Cap Chart
Since September 16, 2020, BioNexus Gene Lab's market cap has decreased from $42.12M to $9.16M, a decrease of -78.25%. That is a compound annual growth rate of -27.05%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 17, 2025 | 11.91M | 137.02% |
| Dec 31, 2024 | 5.03M | -46.33% |
| Dec 29, 2023 | 9.36M | -94.33% |
| Dec 30, 2022 | 165.03M | -54.75% |
| Dec 31, 2021 | 364.69M | 54.35% |
| Dec 31, 2020 | 236.28M | 460.98% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Linde | 216.38B |
| BHP Group | 129.90B |
| Rio Tinto Group | 101.05B |
| The Sherwin-Williams Company | 84.99B |
| Southern Copper | 77.72B |
| Ecolab | 75.90B |
| Newmont | 64.35B |
| Air Products and Chemicals | 64.31B |